NDSN Stock Analysis
NMS · Industrials · Specialty Industrial Machinery
$327.85
+2.08 (+0.64%)
NDSN Interactive Price Chart & Trading Signals
NDSN Stock Snapshot — Valuation, Risk & Technical Signals
NDSN Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Marktkapitalisierung
$18.26B
P/E
33.22
Forward P/E
25.25
PEG
1.86
P/B
5.59
EPS
$9.87
Dividendenrendite
1.15%
52W Spanne
$223.29 – $339.12
Beta
0.97
Volumen
0.0M
ROE
17.8%
Gewinnmarge
18.6%
Umsatzwachstum
10.3%
Bruttomarge
55.4%
EV/EBITDA
20.72
Analystenziel
$349.71
The trailing price-to-earnings ratio stands at 33.2x. Forward P/E of 25.3x implies earnings expansion expected. Price-to-book is 5.59x. EV/EBITDA sits at 20.72x. Market capitalization is $18.26B. Revenue is growing at 10.3% on a trailing basis. Earnings are expanding at 23.0%. Profit margins are 18.6%. Return on equity is 17.8%. Beta of 0.97 indicates market-average volatility.
Analyst Consensus
Empfehlung
Buy
Ziel niedrig
$282.00
Ziel Mittel
$349.71
Ziel hoch
$375.00
Basierend auf 7 Analysten
Über NDSN
Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment. The Medical and Fluid Solutions segment offers precision manual and semi-automated dispensers, plastic molded syringes, cartridges, tips, and fluid connection components; interventional solutions for engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula, and biomaterial delivery; medical fluid components; and microplegia myocardial protection devices and related consumables. The Advanced Technology Solutions segment provides automated dispensing systems for high-speed, precise application of various attachment, protection, and coating fluids, and related gas plasma treatment systems; destructive and non-destructive testing technologies, such as bond testers and automated optical, acoustic microscopy, and x-ray inspection systems used in the semiconductor and printed circuit board industries; and precision measurement and control technologies. The company markets its products through direct sales force, distributors, and sales representatives. Nordson Corporation was founded in 1909 and is headquartered in Westlake, Ohio.
NDSN Deep Dive Analysis
Bottom Line
Verdict
OvervaluedBest for
General investorWatch out for
Premium valuationNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
Nordson Corporation (NDSN) trades above our multi-model fair value estimate of $145.14 by approximately 55.7%. Trailing P/E: 33.2x. Profitability signals include profit margin of 18.6% and return on equity of 17.8%. Recent growth metrics show revenue growth of 10.3% and earnings growth of 23.0%. Risk profile: beta of 0.97. Consensus: buy.
Valuation, Growth & Risk
Valuation
Overvalued
P/E 33.2x
Price is above what fundamentals suggest.
Growth
Expanding
Rev 10.3%
Revenue is outpacing the market.
Valuation Snapshot
Nordson Corporation (NDSN) trades above our multi-model fair value estimate of $145.14 by approximately 55.7%. The trailing price-to-earnings ratio stands at 33.2x. Forward P/E of 25.3x suggests earnings compression ahead. Price-to-sales is 6.1x. Price-to-book is 5.6x. EV/EBITDA sits at 20.7x. Market capitalization is $18.26B.
Why it matters: Paying a premium works only if the company keeps growing faster than expected.
Growth & Profitability
Revenue is growing at 10.3% on a trailing basis. Earnings are expanding at 23.0%. Profit margins are 18.6%. Return on equity is 17.8%. Return on assets is 8.5%.
Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.
Risk Profile
Beta of 0.97 indicates market-average volatility. Net debt position is $1.70B.
Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.
Analyst Context
Analyst consensus target of $349.71 implies 6.7% upside. Target range spans $282.00 to $375.00. 7 analysts cover the stock. Consensus recommendation: buy.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
NDSN Overvalued
Nordson Corporation (NDSN) trades above our multi-model fair value estimate of $145.14 by approximately 55.7%.
Frequently Asked Questions
ValuationIs NDSN stock overvalued right now?
ValuationWhat is NDSN fair value based on current fundamentals?
RiskHow risky is NDSN compared with other stocks?
GrowthIs NDSN still growing?
AnalystWhat do analysts think about NDSN?
DividendDoes NDSN pay a dividend?
CatalystWhat could change the investment case for NDSN?
Related Stocks
เกี่ยวกับผู้เขียน
Phasakorn Traklang (Peach) — ผู้ก่อตั้ง
ภาสกร ตรากลาง (พีช) เป็นผู้ก่อตั้ง QuantSoar และนักวิจัยการลงทุนเชิงปริมาณที่เชี่ยวชาญด้านการประเมินมูลค่าหุ้นหลายโมเดล การวิเคราะห์กระแสสถาบัน และการสร้างพอร์ตแบบเป็นระบบ เขาสร้างแพลตฟอร์มการเงินที่ขับเคลื่อนด้วยข้อมูลเพื่อให้บริการนักลงทุนรายย่อยทั่วโลก
เชื่อมต่อ LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Daten: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub